Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ken J. Park"'
Autor:
Sue Hee Sung, Jennifer L. Kuntz, Matthew Slaughter, Alan S. Go, Kristi Reynolds, Raymond G. Schlienger, Jamie H Thompson, Eric S. Johnson, Abraham Markin, Katarzyna Budzynska, Ken J Park, Tiffany Q. Luong, Douglas W. Roblin, Andrea E. Cassidy-Bushrow, Ming-Sum Lee, Sigrid Behr, Albert Yuh-Jer Shen, Elizabeth T. Mansi, David H. Smith, Jaejin An, Micah L. Thorp
Publikováno v:
Pharmacoepidemiology and Drug Safety. 30:1630-1634
PURPOSE Our objective was to calculate the positive predictive value (PPV) of the ICD-9 diagnosis code for angioedema when physicians adjudicate the events by electronic health record review. Our secondary objective was to evaluate the inter-rater re
Publikováno v:
The Journal of Vascular Access. 22:432-437
Background and objectives: Optimal timing of arteriovenous fistula placement in chronic kidney disease remains difficult and contributes to high central venous catheter use at initial hemodialysis. We tested whether a prediction model for progression
Publikováno v:
The Permanente journal. 25
Use of kidney replacement therapy (KRT) prediction models for guiding arteriovenous fistula (AVF) referrals in advanced chronic kidney disease (CKD) is unknown. We aimed to compare a hypothetical approach using a KRT prediction model developed in Kai
Publikováno v:
Perm J
INTRODUCTION: Achievement of quality metrics in chronic kidney disease (CKD), specifically urinary albumin testing and angiotensin-converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) use, remained lower in Kaiser Permanente North
Publikováno v:
The Permanente journal. 22
CONTEXT Central venous catheter (CVC) use is associated with increased mortality and complications in hemodialysis recipients. Although prevalent CVC use has decreased, incident use remains high. OBJECTIVE To examine characteristics associated with C
Publikováno v:
Seminars in Immunopathology
The diagnosis of rejection in kidney transplant patients is based on histologic classification of a graft biopsy. The current “gold standard” is the Banff 97 criteria; however, there are several limitations in classifying rejection based on biops
Autor:
Teresa M. Holzen, Jeremy M. Grushcow, Douglas K. Bishop, Ted Weinert, Ken J. Park, Michael Lichten
Publikováno v:
Europe PubMed Central
Checkpoint gene function prevents meiotic progression when recombination is blocked by mutations in the recA homologue DMC1. Bypass of dmc1 arrest by mutation of the DNA damage checkpoint genes MEC1, RAD17, or RAD24 results in a dramatic loss of spor